Journal Jam 24 Antibiotics for Strep Throat: Evidence, Myths and Misperceptions

June 2, 2026

AI Summary

5 min read

On a 1951 hospital ward, a patient with a sore throat was given penicillin while another ward of patients was not. That trial, along with others from the same era, still forms the backbone of what clinicians think they know about antibiotics for strep throat. In this episode, the hosts dig into the Cochrane review and the dozens of studies it draws from, and they find that the evidence is far weaker and more complicated than the abstract suggests. The conversation is less about whether antibiotics work and more about how to interpret flawed data, weigh small benefits against real harms, and match treatment decisions to a patient’s actual risk of rare complications like rheumatic fever.

Why the symptom data is unreliable

Continue reading the full summary in the app — free to try.

Read Full Summary →

Free • No credit card required

Listen to Audio Summary Open in App

Never miss an episode of Emergency Medicine Cases

Get every new episode summarized in your inbox — free, ~5 minutes to read.

No spam. Unsubscribe anytime.

What you'll learn

1 (00:05) **Introduction and Framing the Problem** - Anton Hellman and Justin Morganstern welcome Casey Parker to discuss why a seemingly simple topic like strep throat deserves deep evidence-based scrutiny.
2 (03:04) **Why This Topic Matters for Clinical Judgment** - Justin explains that three and a half years of reading this literature changed his practice by letting him individualize care rather than follow a black-and-white rule.
3 (07:45) **Do Antibiotics Actually Make Patients Feel Better Faster?** - The 2021 Cochrane review suggests a modest 12-24 hour reduction in symptom duration with an NNT of 6 at day three, but the hosts immediately flag major methodological concerns.
4 (10:53) **Blinding Bias in the Old Trials** - Casey explains that roughly half of the included trials were unblinded, with randomization done by ward rather than by patient, and that subjective outcomes like pain are highly susceptible to bias.
5 (12:36) **The Swab Timing Problem and Inclusion Criteria** - Justin dissects how the 48-hour wait for culture results creates a fundamental fairness issue in the trials.
6 (16:48) **The Surprising Finding: Antibiotics Work Equally Well for Viral and Strep Pharyngitis** - Justin highlights that multiple trials show antibiotics have the same effect on symptoms regardless of whether the patient swabbed positive for strep.
7 (19:48) **Publication Bias and Researcher Degrees of Freedom** - Casey points out that the funnel plots in the Cochrane review suggest small positive studies are overrepresented, and that older trials often listed many outcomes without a pre-specified primary endpoint.

+ Full timestamped outline available in the app

Show Notes

Antibiotics for strep throat seem like a simple decision—but the evidence is anything but simple. In this Journal Jam podcast with Dr. Casey Parker and Dr. Justin Morgenstern, we critically appraise the literature behind one of the most common infections seen in emergency medicine. Do antibiotics meaningfully improve symptoms? Do they prevent peritonsillar abscess, post-streptococcal glomerulonephritis, or rheumatic fever? How reliable are the studies informing our practice? We explore publication bias, limitations of the Centor score, antibiotic harms, and the importance of local epidemiology, helping clinicians move beyond dogma toward more nuanced, evidence-based decision-making... Please consider a donation to EM Cases to ensure ongoing high quality free open access medical education here: https://emergencymedicinecases.com/donation/